My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Apple Q2 Preview: A New CEO, AI Doubts — Ever...
Alphabet's 'Phenomenal' Quarter Powers Bigges...
Royal Caribbean Delivers Profit Surprise, Sto...
AI Memory Crunch Sends Storage Stocks Higher...
Caterpillar's Profit Engine Fires, But Tariff...
Microsoft Stock Falls On Q3 Earnings: Analyst...
Homeowners Insurance Premiums Jump 64% Since...
SoftBank Eyes 2026 IPO For New AI-Robotics Ve...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    JOHNSON & JOHNSON (NYSE: JNJ)

    Overview
    current price
    $229.85
    $229.85
    change
    2.50 | 1.10%
    2.50 | 1.10%
    Yesterday's Close
    227.35
    open
    227.95
    volume
    8.16 M
    30d. avg volume.
    7.76 M
    1 day
    227.81 - 231.16
    52 weeks
    146.12 - 251.71
    p/e
    26.34
    beta
    0.3367
    market cap
    547.28 B
    dividend yield
    2.36%
    Industry
    -
    JNJ by TradingView
    News and Commentary
    Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst Johnson & Johnson (JNJ
    Market Update: Stocks Rise on Extended Ceasefire Optimism Stocks rose higher Monday as market participants held onto optimism that the United States and Iran will reach a peace deal over the next couple of days.
    Microsoft Is Now The Biggest Deadweight On S&P 500 — And Exxon Is What Nvidia Used To Be Microsoft Corp. (MSFT
    Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report The Trump administration is reportedly preparing to announce 100% tariffs on pharmaceutical companies that have not secured pricing deals with the White House.
    Johnson & Johnson Expects 2026 Sales To Hit Almost $100 Billion Johnson & Johnson (JNJ
    Market Update: Dow Rallies 560 Points to Record Close The Dow Jones Industrial Average soared to a new record closing high on Tuesday as market participants rotated out of technology names into stocks with lower valuations.
    Microsoft, Meta Stocks Add $440 Billion In A Day—Nearly Matching Netflix's Entire $503 Billion Marke... Microsoft Corp. (MSFT&...
    Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Co... The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug p...
    3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs On July 8, US President Donald Trump shook the biopharmaceutical sector by announcing a tariff of up to 200% on pharmaceuticals, which would take effect "very soon." 80% of presc...
    Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
    StockTwits
    StockTwits
    Most Shared
    IBM AI Success Faces Macro Headwinds: Analyst Cuts Price Target
    SpaceX IPO Would Test A Brutal Truth: Most IPOs Since 2021 Destroyed Value
    US Economy Stays Resilient, But 'Significant Risks' Are Building Fast, Jamie Dimon Warns
    Most Popular
    AMD Says Space Needs Smarter Chips Now And It's Ready To Deliver
    SpaceX IPO Would Test A Brutal Truth: Most IPOs Since 2021 Destroyed Value
    Watch Out Tesla ― NIO March Deliveries Surged 136%
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?